ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	3/11	120/7206	0.000674083529173
ko05213	Endometrial cancer	2/11	62/7206	0.00381105234612
ko05223	Non-small cell lung cancer	2/11	66/7206	0.00430857215997
ko05214	Glioma	2/11	79/7206	0.00612201151205
ko05230	Central carbon metabolism in cancer	2/11	81/7206	0.00642722994048
ko05212	Pancreatic cancer	2/11	83/7206	0.006739336873
ko05218	Melanoma	2/11	85/7206	0.0070582953544
ko04662	B cell receptor signaling pathway	2/11	88/7206	0.00754949920344
ko05146	Amoebiasis	2/11	99/7206	0.00947977042577
ko01521	EGFR tyrosine kinase inhibitor resistance	2/11	106/7206	0.0108118323453
ko04012	ErbB signaling pathway	2/11	109/7206	0.0114069384847
ko05215	Prostate cancer	2/11	111/7206	0.0118116614664
ko04066	HIF-1 signaling pathway	2/11	123/7206	0.0143720699243
ko04660	T cell receptor signaling pathway	2/11	124/7206	0.0145955156759
ko01522	Endocrine resistance	2/11	124/7206	0.0145955156759
ko04915	Estrogen signaling pathway	2/11	131/7206	0.0162022463032
ko04630	Jak-STAT signaling pathway	2/11	132/7206	0.0164378152198
ko05231	Choline metabolism in cancer	2/11	134/7206	0.0169134375484
ko04931	Insulin resistance	2/11	137/7206	0.0176380189173
ko04670	Leukocyte transendothelial migration	2/11	151/7206	0.0211931225324
ko05160	Hepatitis C	2/11	153/7206	0.0217239319139
ko04621	NOD-like receptor signaling pathway	2/11	157/7206	0.0228024252113
ko04068	FoxO signaling pathway	2/11	167/7206	0.0255955802779
ko05224	Breast cancer	2/11	174/7206	0.0276315015939
ko05152	Tuberculosis	2/11	187/7206	0.0315837088845
ko04060	Cytokine-cytokine receptor interaction	2/11	191/7206	0.0328434922692
ko04072	Phospholipase D signaling pathway	2/11	197/7206	0.0347708603348
ko00514	Other types of O-glycan biosynthesis	1/11	30/7206	0.0448842130032
ko04320	Dorso-ventral axis formation	1/11	31/7206	0.0463482979607
ko04510	Focal adhesion	2/11	240/7206	0.0498379403167